Tetracycline derivative (Paratek Pharmaceuticals)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameTetracycline derivative (Paratek Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Tetracycline antibiotics
Mechanisms of Action30S ribosomal subunit inhibitors
Targets30S ribosomal subunit
Therapy Area/IndicationsClostridium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesParatek Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesParatek Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsClostridium Infections

Other Information

ATC CodeN/A
Related LinksN/A